Scyx market cap
Webb11 apr. 2024 · Diffusion Pharmaceuticals (NASDAQ:DFFN) Earns Hold Rating from Analysts at StockNews.com. Posted by MarketBeat News on Apr 11th, 2024 WebbAs of March 2024 SCYNEXIS has a market cap of $54.53 Million. This makes SCYNEXIS the world's 6782th most valuable company by market cap according to our data. The …
Scyx market cap
Did you know?
Webb11 apr. 2024 · April 11, 2024 3:02 am. Last Updated: April 11, 2024 12:04 pm. On April 10, 2024 at 10:52:25 ET an unusually large $37.65K block of Call contracts in SCYNEXIS (SCYX) was sold, with a strike price ... WebbA list of the biggest pharmaceutical and drug company stocks, ranked by market cap.
Webb13 apr. 2024 · The small-cap Russell 2000 won the week, up 2.4%, enough to return it to positive territory for 2024, up 2.0%. The fractal dimension is still headed towards the 55 level that will signal a real new trend is underway. If the market continues to rise, even just a little, it should begin accelerating towards 55 in a couple of weeks. Webb6 apr. 2024 · As of last trade, SCYNEXIS Inc (SCYX:NMQ) traded at 1.40, 12.90% above the 52 week low of 1.24 set on Mar 13, 2024. 52-week range Today 1.24 Mar 13 2024 5.15 Mar 23 2024 Short selling activity...
Webb21 mars 2024 · Market Cap $115.63 M Shares Outstanding 33.32 M Public Float 31.96 M Yield SCYX is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend … Webb22 mars 2024 · SCYNEXIS (NASDAQ:SCYX) adds US$9.1m to market cap in the past 7 days, though investors from five years ago are still down 88% Simply Wall St Published March 22, 2024 Source: Shutterstock This week we saw the SCYNEXIS, Inc. ( NASDAQ:SCYX) share price climb by 22%.
Webb31 mars 2024 · JERSEY CITY, N.J., March 31, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today reported financial results for the fourth quarter and full year ended on December 31, 2024.
Webb22 mars 2024 · SCYNEXIS (NASDAQ:SCYX) adds US$9.1m to market cap in the past 7 days, though investors from five years ago are still down 88%. Simply Wall St. Published … bs チャンネル 増えるWebbInstitutional ownership of SCYX stands at $14.6 million shares or 44.69% of shares outstanding. This is in-line with the Pharmaceuticals: Other industry average. Largest Quarterly Institutional... bs チャンネル 周波数 一覧http://www.foxchart.com/index.php?symbol=SCYX bs チャンネル 廃止WebbSCYNEXIS to Present Ibrexafungerp Data at the 33rd Annual European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) April 15-18 in Denmark - Investoreight 太陽光 電子申請 ログインWebbFör 1 dag sedan · SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp … bs チャンネル 変更Webb1 mars 2024 · Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include … 太陽堂スポーツ 足立WebbFör 1 dag sedan · SCYNEXIS (SCYX) Price To Cash Flow - Zacks.com SCYNEXIS (SCYX) (Real Time Quote from BATS) $3.22 USD +0.14 (4.55%) Updated Apr 13, 2024 02:16 PM ET Add to portfolio Zacks Rank: 2-Buy 2 Style... 太陽熱利用システム エコキュート